MMedication Read More FDA Seeks Schedule I Status for ‘Legal Morphine’31 July 2025 The FDA is recommending that 7-hydroxymitragynine (7-OH), a synthetic, concentrated substance derived from kratom leaves, be classified as…
MMedication Read More Most GLP-1 Prescriptions Miss the Mark: Are Yours?29 July 2025 GLP-1 receptor agonists, including semaglutide, are now widely used for weight loss, offering substantial weight reduction, improved metabolic…
GGenetics Read More Genetics or Microenvironment: What Drives CLL Progression?19 June 2025 MILAN — Is chronic lymphocytic leukemia (CLL) progression primarily driven by genetic mutations or by external cues from…
MMental health Read More How One Dose of Psilocybin Treats Depression17 June 2025 This transcript has been edited for clarity. Welcome to Impact Factor, your weekly dose of commentary on a…
GGenetics Read More Dog Exposure Affects Genetic Risk in Eczema, Study Finds6 June 2025 TOPLINE: Children with a genetic variant linked to atopic eczema (rs10214237) appeared less likely to develop the condition…
MMedication Read More Alternatives to GLP-1 Medications for Weight Loss – Medscape11 April 2025 Alternatives to GLP-1 Medications for Weight Loss Medscape Weight-loss drugs offer hope, but no magic pill for obesity, say…